European study of COVID-19 vaccine effectiveness against hospitalised SARI patients laboratory-confirmed with SARS-CoV-2: I-MOVE-COVID-19 generic protocol

This document presents the core I-MOVE-COVID-19 European protocol for the 2020 hospital-based study of vaccine effectiveness against COVID-19 in hospitalised SARI patients of all ages, outlining the agreed methods for collecting data on COVID-19 and SARS-CoV-2 in each of the individual studies, and including a plan for the pooled analysis.This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 10100367